Studies have shown that a GLP-1 drug, exenatide, sufficiently crosses the blood-brain barrier in rodent models of Parkinsons disease, leading to improvements in motor performance, behavior, learning and memory
Understanding the metabolic context helps explain why nutritional support matters during GLP-1 treatment
You are far from alone in your frustrating endeavors to lose weight and keep it off
The systematic review using PRISMA guidelines yielded 1,490 initial articles, of which 937 were screened and 10 met the inclusion criteria
GLP-1 comparison guide: Ozempic vs Wegovy vs Mounjaro vs Zepbound Knowing the differences between these medications is important, but can also be confusing
Rawson, E.S., & Venezia, A.C